Clincosm LogoSign in Get a demo

Two Cases of Pulmonary Cysticercosis Manifesting as Pleural Effusion: Case Report and Literature Review

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University (Other)
Overall Status
Completed
CT.gov ID
NCT05010811
Collaborator
(none)
2
Enrollment
6.2
Actual Duration (Months)

Study Details

Study Description

Brief Summary

Isolation lung cysticercosis reports are rare in literature. Most lung lesions were characterized by nodules. The investigators access one case which was characterized with pulmonary cavity and pleural effusion by Gupta N, et al in 2015 from PUBMED and Medline. But pleural effusion and exudative lesions is reported for the first time.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Cysticercosis is an important public health problem in developing countries. The major involvement sites are the central nervous system and the eyes，although striated muscles and subcutaneous tissues are frequently involved in the disseminated form of disease. Pulmonary involvement in cysticercosis is very rare and ill-defined nodular shadows distributed throughout the lung is the usual radiological presentation. Only one case of cysticercosis presenting as lung cavity with pleural effusion has been reported so far in literature. The investigators describe two cases in which pleural effusion due to cysticercosis were detected on X and CT.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    2 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Two Cases of Pulmonary Cysticercosis Manifesting as Pleural Effusion: Case Report and Literature Review
    Actual Study Start Date :
    Oct 22, 2016
    Actual Primary Completion Date :
    Jan 18, 2017
    Actual Study Completion Date :
    Apr 28, 2017

    Outcome Measures

    Primary Outcome Measures

    1. Amount of pleural effusion [9 months]

      cm

    2. Rate of Eosinophil ratio [9 months]

      Percentage（%）

    3. Changes of lesions under chest radiography or CT [9 months]

      no change, change, complete absorption

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    45 Years to 67 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    1. Clinical diagnosis of Pulmonary Cysticercosis。

    2. With pleural effusion

    Exclusion Criteria:

    1.No cysticercosis was found by biopsy or antibody test

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Second Affiliated Hospital, School of Medicine, Zhejiang University

    Investigators

    • Study Director: Pingli Wang, MD, the same research center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Second Affiliated Hospital, School of Medicine, Zhejiang University
    ClinicalTrials.gov Identifier:
    NCT05010811
    Other Study ID Numbers:
    • 2016-122
    First Posted:
    Aug 18, 2021
    Last Update Posted:
    Aug 30, 2021
    Last Verified:
    Sep 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Second Affiliated Hospital, School of Medicine, Zhejiang University
    Cysticercosis
    pleural effusion
    pulmonary
    Additional relevant MeSH terms:
    Cysticercosis
    Taeniasis
    Neurocysticercosis
    Pleural Effusion

    Study Results

    No Results Posted as of Aug 30, 2021